CMR Tissue Characterization in Patients with HFmrEF
Authors:
- Patrick DoeblinPDPatrick Doeblin
- Djawid HashemiDHDjawid Hashemi
- Radu TanacliRTRadu Tanacli
- Tomas LapinskasTLTomas Lapinskas
- Rolf GebkerRGRolf Gebker
- Christian StehningCSChristian Stehning
- Laura Astrid MotzkusLMLaura Astrid Motzkus
- Moritz BlumMBMoritz Blum
- Elvis TahirovicETElvis Tahirovic
- Aleksandar DordevicADAleksandar Dordevic
- Robin KraftRKRobin Kraft
- Seyedeh Mahsa ZamaniSZSeyedeh Mahsa Zamani
Open Access
- 5 November 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (11) , 1877
Abstract
The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adverse cardiac remodeling. We, therefore, examined 17 patients with HFpEF, 18 with HFmrEF, 17 with HFrEF and 17 healthy, age-matched controls with cardiac MRI (Phillips 1.5 T). T1 and T2 relaxation time mapping was performed and the extracellular volume (ECV) was calculated. Global circumferential (GCS) and longitudinal strain (GLS) were derived from cine images. GLS (−15.7 ± 2.1) and GCS (−19.9 ± 4.1) were moderately reduced in HFmrEF, resembling systolic dysfunction. Native T1 relaxation times were elevated in HFmrEF (1027 ± 40 ms) and HFrEF (1033 ± 54 ms) compared to healthy controls (972 ± 31 ms) and HFpEF (985 ± 32 ms). T2 relaxation times were elevated in HFmrEF (55.4 ± 3.4 ms) and HFrEF (56.0 ± 6.0 ms) compared to healthy controls (50.6 ± 2.1 ms). Differences in ECV did not reach statistical significance. HFmrEF differs from healthy controls and shares similarities with HFrEF in cardiac MRI parameters of fibrosis and inflammation.Keywords
This publication has 38 references indexed in Scilit:
- Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance studyJournal of Cardiovascular Magnetic Resonance, 2014
- CMR-Verified Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HFpEFJACC: Cardiovascular Imaging, 2014
- T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsyEuropean Heart Journal - Cardiovascular Imaging, 2014
- Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathyThe International Journal of Cardiovascular Imaging, 2014
- Developing Therapies for Heart Failure With Preserved Ejection FractionJACC: Heart Failure, 2014
- Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathologyEuropean Heart Journal, 2012
- Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 MappingCirculation: Cardiovascular Imaging, 2012
- Direct T2 Quantification of Myocardial Edema in Acute Ischemic InjuryJACC: Cardiovascular Imaging, 2011
- Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heartMagnetic Resonance in Medicine, 2004
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJACC, 2000